Literature DB >> 516068

Allylamine cardiotoxicity: I. Sequence of pathologic events.

P J Boor, M T Moslen, E S Reynolds.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 516068     DOI： 10.1016/0041-008x(79)90413-7

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  7 in total

1.  Allylamine-induced phenotypic modulation of aortic smooth muscle cells.

Authors:  L R Cox; K Ramos
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

2.  Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism.

Authors:  S O Awe; A S O Adeagbo; S E D'Souza; A Bhatnagar; D J Conklin
Journal:  Toxicol Appl Pharmacol       Date:  2006-08-26       Impact factor: 4.219

3.  Allylamine cardiotoxicity: II. Histopathology and histochemistry.

Authors:  P J Boor; T J Nelson; P Chieco
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

4.  Acrolein generation stimulates hypercontraction in isolated human blood vessels.

Authors:  D J Conklin; A Bhatnagar; H R Cowley; G H Johnson; R J Wiechmann; L M Sayre; M B Trent; P J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2006-09-29       Impact factor: 4.219

5.  Ultrastructural alterations in allylamine cardiovascular toxicity. Late myocardial and vascular lesions.

Authors:  P J Boor; V J Ferrans
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

Review 6.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

7.  Effect of various non-hepatotoxic compounds on urinary and liver taurine levels in rats.

Authors:  C J Waterfield; J A Turton; M D Scales; J A Timbrell
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.